Population: Infants (<1 year)

RESP-VIR

Italy
|
2025-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Non-hospital health centre
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Parainfluenza Virus
  • Metapneumovirus

NIRSE-GAL

Spain
|
2023-2026
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Primary care
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

IMAR

Sweden
|
2018-2022
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Intensive care unit
  • Respiratory syncytial virus

Nur Vural

Türkiye
|
2023-2024
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Non pharmacological intervention
  • Lung ultrasound

IRIS 2

The Netherlands
|
2025
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Primary care
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

BronchSTART

United Kingdom Ireland
|
2021-2026
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Respiratory syncytial virus

Cocchi

Italy
|
2023-2025
  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

ZIKAllianceCH

Bolivia (Plurinational State of) Brazil Colombia Guadeloupe Mexico Venezuela (Bolivarian Republic of)
|
2018-2022
  • Adults (18-64 years)
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Pregnant women
  • Community
  • Arbovirus
  • Vector-borne disease
  • Zika virus
  • Blood sample
  • Urine sample
  • Hair
  • Saliva
  • Semen
  • Vaginal fluids

CARBO

France French Guiana Guadeloupe Martinique Réunion
|
2010-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • Emergency department
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • Zika virus
  • West Nile virus
  • Japanese encephalitis virus

Buonsenso

Italy
|
2021-2024
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome

Kautsch

Poland
|
2020-2023
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

ECRAID-EU-RECOVERY

France Italy The Netherlands Belgium Estonia Portugal Romania Spain Sweden
|
2020
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Pharmacological intervention
  • Antivirals
  • Corticosteroid
  • Baloxavir
  • Oseltamivir